4D Molecular Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
4D Molecular Therapeutics, Inc. (FDMT) reported Increase (Decrease) in Other Noncurrent Assets of $652.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-13
- 4D Molecular Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$18.00K, a 100.77% decline year-over-year.
- 4D Molecular Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $670.00K, a 75.92% decline year-over-year.
- 4D Molecular Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$192.00K, a 113.75% decline year-over-year.
- 4D Molecular Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$10.00K, a 101.83% decline year-over-year.
- 4D Molecular Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $4.93M, a 37.74% increase from fiscal 2024.
- 4D Molecular Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $3.58M, a 5010.00% increase from fiscal 2023.
- 4D Molecular Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $70.00K, a 536.36% increase from fiscal 2022.
- 4D Molecular Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $11.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $652.00K 10-Q · filed 2026-08-13 | $460.00K derived: sum of 3 quarters · filed 2026-08-13 | $450.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $670.00K 10-Q · filed 2026-05-07 | $478.00K derived: sum of 2 quarters · filed 2026-05-07 | $468.00K derived: sum of 3 quarters · filed 2026-05-07 | $2.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$202.00K derived: sum of 2 quarters · filed 2026-03-18 | $2.15M derived: sum of 3 quarters · filed 2026-08-13 | $4.93M 10-K · filed 2026-03-18 |
| 2025-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.34M derived: sum of 2 quarters · filed 2026-08-13 | $5.12M 10-Q · filed 2025-11-10 | $6.51M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $2.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $5.13M 10-Q · filed 2026-08-13 | $6.53M derived: sum of 3 quarters · filed 2026-08-13 | $7.07M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $2.78M 10-Q · filed 2026-05-07 | $4.18M derived: sum of 2 quarters · filed 2026-05-07 | $4.72M derived: sum of 3 quarters · filed 2026-05-07 | $6.27M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.94M derived: sum of 2 quarters · filed 2026-03-18 | $3.49M derived: sum of 3 quarters · filed 2026-03-18 | $3.58M 10-K · filed 2026-03-18 |
| 2024-09-30 | $545.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $2.09M derived: sum of 2 quarters · filed 2025-11-10 | $2.18M 10-Q · filed 2025-11-10 | $2.18M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $1.64M 10-Q · filed 2025-08-11 | $1.64M derived: sum of 3 quarters · filed 2025-08-11 | $1.71M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $88.00K 10-Q · filed 2025-05-08 | $89.00K derived: sum of 2 quarters · filed 2025-05-08 | $158.00K derived: sum of 3 quarters · filed 2025-05-08 | $48.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $70.00K derived: sum of 2 quarters · filed 2025-02-28 | -$40.00K derived: sum of 3 quarters · filed 2025-02-28 | $70.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$41.00K derived: sum of 2 quarters · filed 2024-11-13 | $69.00K 10-Q · filed 2024-11-13 | -$371.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | -$440.00K derived: sum of 3 quarters · filed 2024-08-08 | |
| 2023-03-31 | $110.00K 10-Q · filed 2024-05-09 | -$330.00K derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$440.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $11.00K 10-K · filed 2024-02-29 | ||
| 2022-09-30 | $451.00K 10-Q · filed 2023-11-09 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | $0.00 derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 derived: sum of 2 quarters · filed 2023-03-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2022-03-28 | -$60.00K derived: sum of 4 quarters · filed 2022-03-28 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | -$60.00K derived: sum of 3 quarters · filed 2022-03-28 | -$57.00K derived: sum of 4 quarters · filed 2022-03-28 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$60.00K derived: sum of 2 quarters · filed 2022-03-28 | -$57.00K derived: sum of 3 quarters · filed 2022-03-28 | -$75.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$57.00K derived: sum of 2 quarters · filed 2021-11-10 | -$75.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$15.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$18.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $220.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Entera Bio Ltd. (ENTX) | $0.485B |